BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 208764)

  • 1. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Stout DL; Becker FF
    Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
    [No Abstract]   [Full Text] [Related]  

  • 2. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
    Castro CE; Felkner IC; Yang SP
    Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
    Schut HA; Thorgeirsson SS
    Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
    [No Abstract]   [Full Text] [Related]  

  • 4. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation.
    Stout DL; Baptist JN; Matney TS; Shaw CR
    Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of 2-aminofluorene and 2-acetylaminofluorene to mutagens by rat hepatocyte nuclei.
    Stout DL; Becker FF
    Cancer Res; 1979 Apr; 39(4):1168-73. PubMed ID: 421200
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution of alpha-fetoprotein- and albumin-containing cells in the livers of Fischer rats fed four cycles of N-2-fluorenylacetamide.
    Sell S
    Cancer Res; 1978 Sep; 38(9):3107-13. PubMed ID: 79445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Binding of 2-acetylaminofluorene-9-14C with rat liver nucleic acids during malignization and in primary hepatomas].
    Ivanov SD; Dzhioev FK
    Biull Eksp Biol Med; 1977 Mar; 83(3):332-4. PubMed ID: 192387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations.
    Kurelec B; Krca S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):171-7. PubMed ID: 2890481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cholesterol biosynthesis in rat liver after the administration of N-2-fluorenylacetamide.
    Calandra S; Guariento D; Rivasi F
    Lab Invest; 1973 Jun; 28(6):723-7. PubMed ID: 4351645
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse.
    Sakai S; Reinhold CE; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1978 Jul; 38(7):2058-67. PubMed ID: 26463
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
    Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
    Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
    Jacobs MM; Matney TS; Griffin AC
    Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
    McGregor D
    Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive RNA-DNA hybridization of nuclear and microsomal RNA during diethylnitrosamine hepatocarcinogenesis.
    Garrett CT; Katz C; Moore RE; Pitot HC
    Cancer Res; 1973 Jul; 33(7):1662-9. PubMed ID: 4352795
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytochrome P-450 in hyperplastic liver nodules during hepatocarcinogenesis with N-2-fluorenylacetamide in rats.
    Okita K; Noda K; Fukumoto Y; Takemoto T
    Gan; 1976 Dec; 67(6):899-902. PubMed ID: 191326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of monooxygenases in rhesus monkeys by 3-methylcholanthrene: metabolism and mutagenic activation of N-2-acetylaminofluorene and benzo(a)pyrene.
    Thorgeirsson SS; Sakai S; Adamson RH
    J Natl Cancer Inst; 1978 Feb; 60(2):365-9. PubMed ID: 413928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrophotometric analysis of cytochromes in rat liver during carcinogenesis.
    Oyanagui Y; Sato N; Hagihara B
    Cancer Res; 1974 Mar; 34(3):458-62. PubMed ID: 4359875
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of aminothiols in 2-acetylaminofluorene-treated rats. III. Metabolic activation of aromatic amines.
    De Flora S; Camoirano A; Bennicelli C; Orunesu M; Cesarone CF
    In Vivo; 1987; 1(2):101-7. PubMed ID: 2979769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.